Advances in Solid and Semi-Solid Dosage Form Design for Enhanced Biopharmaceutical Performance

Dear Colleagues,

The development of solid and semi-solid dosage forms represents a cornerstone of modern pharmaceutical sciences, offering advantages such as stability, ease of administration, and cost-effective manufacturing. However, challenges such as poor solubility, low bioavailability, inconsistent drug release, and regulatory complexities continue to drive innovation in formulation and drug delivery technologies. The need for advanced formulation strategies and innovative manufacturing techniques has never been greater. These approaches could be transformative in enhancing therapeutic efficacy, patient compliance, and commercial viability.

This Special Issue will highlight cutting-edge research and technological advancements in solid and semi-solid dosage form design to improve biopharmaceutical properties. We invite the submission of original research articles and comprehensive reviews that explore novel approaches to enhancing drug solubility, bioavailability, and controlled release, as well as advanced manufacturing methods that align with modern regulatory and quality-by-design (QbD) principles.

The rapid evolution of pharmaceutical formulation sciences necessitates continuous research to optimize drug delivery, enhance patient compliance, and meet regulatory standards. This Special Issue will provide a platform for researchers, industry professionals, and regulatory experts to share their latest breakthroughs, challenges, and perspectives in the field of solid and semi-solid dosage forms.

We encourage contributions from academia, industry, and regulatory agencies that showcase interdisciplinary advancements and real-world applications. Your research will help shape the future of pharmaceutical development and improve therapeutic outcomes.

We look forward to receiving your valuable contributions.

Dr. Abdullah Alzahrani
Dr. Ádám Haimhoffer
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.